Loading market dashboard
Aquestive Therapeutics, Inc.
AQSTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Aquestive Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $252.61M | $217.11M - $307.70M | -$159.48M | $0.205 | 3 |
| Dec 2029 | $168.57M | $144.88M - $205.33M | -$106.42M | -$0.03 | 3 |
| Dec 2028 | $100.71M | $86.56M - $122.68M | -$63.58M | -$0.288 | 4 |
| Dec 2027 | $70.19M | $63.37M - $75.22M | -$44.32M | -$0.444 | 5 |
| Dec 2026 | $50.52M | $45.95M - $53.59M | -$31.89M | -$0.421 | 7 |
| Dec 2025 | $44.80M | $42.83M - $45.70M | -$28.29M | -$0.619 | 7 |
| Dec 2024 | $58.81M | $57.81M - $60.90M | -$37.13M | -$0.436 | 7 |
| Dec 2023 | $58.36M | $50.16M - $71.09M | -$36.84M | -$0.347 | 6 |
| Dec 2022 | $47.40M | $46.96M - $47.84M | -$28.54M | -$1.046 | 2 |
| Dec 2021 | $49.10M | $41.70M - $57.10M | -$29.57M | -$1.524 | 3 |
| Dec 2020 | $44.91M | $38.14M - $52.22M | -$27.04M | -$1.534 | 3 |
| Dec 2019 | $52.04M | $44.19M - $60.51M | -$31.33M | -$2.44 | 2 |